DementiaBWIBS-WMNCT07673770
Brain Wave Informed Non-invasive Brain Stimulation: Improving Neural Networks of Working Memory in Dementia: a Proof-of-concept Study
A study testing EEG-triggered TMS in people with Dementia and Alzheimer s Disease, run by McMaster University at 1 site in Canada.
Trial summary
Working memory helps us hold information for a short time so one can think and make decisions. It keeps thoughts on track. As one gets older, working memory gets weaker. In people with dementia, it gets much worse, making it harder to talk with others, follow directions, or remember things like shopping lists. Read more about this study
- Who is it for?
- Ages 55 years and older
- Conditions the study is for
- Dementia, Alzheimer s Disease
- What is being tested?
- EEG-triggered TMS
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteCanada
- Study dates
- 7 Jul 2026to 1 Aug 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 55 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Individuals must be diagnosed with Alzheimer's Disease or related dementias by a clinician.
- Individuals must exhibit adequate oral communication skills and cognitive function sufficient to obtain a score above 10 on the MMSE
- Instructions will be delivered in English; therefore participants must demonstrate an understanding of instruction provided in English.
- Individuals must be at least 55 years or older
Who cannot join
- Contraindications to TMS; presence of a pacemaker, metal/electrical/magnetic implants not including titanium, known history of untreated or uncontrolled psychological disorders, pregnancy, history of seizure or diagnoses of epilepsy, are taking any prescription medications that increase the risk of seizure.
- Allergy to rubbing alcohol, which is needed to prepare electromyography for TMS
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Ameer Hamoodi contact
Canada1 site, 1 recruiting
- Recruiting
Ivor Wynne Center
Hamilton, Ontario, L8S 4L8
Aimee Nleson, PhD, 9055259140 Ext. 28053, nelsonaj@mcmaster.ca
About this study
Working memory helps us hold information for a short time so one can think and make decisions. It keeps thoughts on track. As one gets older, working memory gets weaker. In people with dementia, it gets much worse, making it harder to talk with others, follow directions, or remember things like shopping lists.
This may happen because brain waves that support working memory fall out of sync. Researchers can see these brain waves using a test called EEG. In this study, the investigators will try to get these brain waves back in sync using a safe, non-invasive form of brain stimulation called transcranial magnetic stimulation (TMS), and will time it to each person's brain waves to make it more effective. The goal is to improve working memory in people with dementia. If successful, dementia patients may be able to be more independent taking pressure off their families.
Read the detailed description
Dementia is cognitive decline severe enough to interfere with daily function and is more severe than cognitive decline normally occurring as a result of aging. Two major cognitive domains which are typically impaired in dementia include executive function and learning/memory. Impairments in executive function interfere with an individual's ability to plan, organize, and switch between tasks, with impairments in this domain significantly reducing an individual's ability to perform activities of daily living (ADL). In the learning/memory domain, episodic memory and working memory are altered. Impairments in episodic memory lead to individuals being unable to recall past events or experiences, as well as being unable to learn and retain details about new experiences. Impairments in working memory lead to individuals being unable to retain information for short periods of time during the execution of a task, such as remembering what was said earlier in a conversation or remembering a set of instructions while executing them. Similar to executive function, decline in episodic and/or working memory is related to reduced ADL. Lower ADL in patients with dementia is associated with higher burden on their caregivers. Dementia caregivers in Canada provide over 580 million hours of care annually. Dementia produces a ripple effect for all Canadians through hospital stays and emergency department visits, loss of productivity from absenteeism, presenteeism, and early retirement of caregivers leading to an overall annual economic burden of over $10 billion CAD. At present, there is no gold standard treatment for reducing cognitive impairment in dementia.
While dementia is thought to be a result of a combination of structural and chemical changes in the brain, recent work has highlighted the interaction between these changes and how the brain functionally adapts to them. The 2024 Lancet Neurology Commission on dementia highlights some individuals may have the chemical and structural brain changes associated with dementia, but do not suffer cognitive decline beyond what is associated with normal aging. More specifically, a community-based autopsy study of 4,354 individuals over the age of 80 in the United Kingdom measured the number of neuropathologies including severe neuritic plaques, neurofibrillary tangles, micro \& macroinfarcts, and Lewy bodies, found that 51% of individuals with two or more significant neuropathologies did not have a clinical diagnosis of dementia. The brain's ability to withstand neuropathology without leading to cognitive decline is defined as cognitive reserve. Cognitive reserve is thought to allow recruitment of brain networks typically used for other functions or more efficient use of existing brain networks. On a neurophysiological level, it is thought that individuals with higher cognitive reserve generally have higher resting state functional connectivity between regions involved in cognition. Thus, increasing functional connectivity between brain regions involved in cognitive domains impaired in dementia may be able to improve cognitive reserve, reducing cognitive impairment in dementia.
Electroencephalography (EEG) is an effective method for measuring functional connectivity between brain regions non-invasively. EEG functional connectivity associated with proper functioning of cognitive domains impaired in dementia may provide a target biomarker to improve cognitive reserve. While EEG functional connectivity during executive function and episodic memory have been measured, there is a large degree of overlap in functional connectivity changes between executive function and working memory, likely due to both sharing some cognitive processes. Further, there are multiple studies demonstrating the causal role of EEG functional connectivity measures in working memory. Thus, EEG functional connectivity associated with working memory may provide a more promising biomarker to target for cognitive reserve.
EEG functional connectivity is a measure of the synchrony between EEG waves from two different brain regions. During successful working memory maintenance, the level of synchrony in the theta band between the frontal and temporal cortex has been shown to increase in healthy adults. Frontotemporal theta band synchrony is most commonly measured through phase-locking value (PLV). High PLV is thought to indicate stronger communication between cortices. Further, temporarily enhancing frontotemporal theta PLV using non-invasive brain stimulation known as transcranial alternating current stimulation (tACS) has been shown to restore working memory performance in older adults to the level of healthy young adults. Additionally, a metanalysis of 28 placebo-controlled studies determining the effects of different tACS protocols on working memory, found that only two forms of tACS improved working memory performance: frontotemporal theta and occipitoparietal gamma. Occipitoparietal gamma was thought to improve working memory performance as a result of many of the included studies using visual based working memory tasks. Nonetheless, these findings provide strong evidence for the role of frontotemporal theta PLV in working memory and highlight the potential for improving cognition by improving frontotemporal theta PLV long-term. At present, tACS is the only approach that can effectively improve PLV between two brain regions. However, its effects are typically temporary, lasting between 30min-70min after stimulation. Thus, enhancing PLV between two brain regions long-term may potentially produce lasting improvements in cognition in dementia.
High PLV is thought to occur due to strong synapses between two populations of neurons being recorded via EEG. If the strength of the synapses between these two populations were increased, then, theoretically their PLV would likely also increase. In the context of working memory, strengthening the synapses between neurons in the frontal and temporal cortex that generally contribute to the EEG theta band may result in a significant increase in frontotemporal theta PLV on EEG. These synapses can potentially be strengthened through a form of neuroplasticity known as long-term potentiation (LTP). LTP can potentially be induced through spike-timing dependent plasticity. Spike-timing dependent plasticity occurs through co-incident firing of the sending and receiving neurons. Considering that the frontal cortex is largely considered to be the hub for most cognitive functions, it is suggested that the frontal cortex projects onto the temporal cortex. Therefore, stimulating the frontal cortex when neurons in the temporal cortex contributing to the theta band are most likely to fire action potentials, through spike-timing dependent plasticity, may result in theta band specific LTP between the frontal and temporal cortex, in turn producing long-term enhancements in frontotemporal theta PLV.
The probability that a population of neurons will fire an action potential has previously been shown to be related to the phase of the EEG band. More specifically, non-invasive brain stimulation known as transcranial magnetic stimulation (TMS), synchronized to mu (8-13Hz) troughs results in significantly greater muscle activity than peaks or random phases. This is thought to be a result of the cortex being more excitable at troughs than any other phase. Therefore, triggering TMS over the frontal cortex at temporal cortex theta troughs, while accounting for conduction delay between the two cortices, may induce EEG theta band specific LTP between the two cortices. This approach has not been used in healthy adults or in clinical populations including Alzheimer's disease and related dementias.
The goal of this study open-label proof-of-concept study is to determine the feasibility and potential efficacy of the approach of temporal cortex theta trough triggered frontal TMS. This study will inform the design of a powered study to observe effects of EEG-TMS on working memory and will inform future work to identify and target biomarkers of other impacted cognitive domains in dementia. This study also aims to determine the potential of this technique to produce long-term improvements in working memory \& cognition in individuals suffering from dementia as well as improvements in frontotemporal theta PLV.
By improving working memory in dementia, overall cognition may be improved, dementia patients' ADL may increase, and strain on their caregivers may be reduced. This study paves the way for future work that aims to improve the cognitive domains impaired in dementia by targeting the neurophysiological biomarkers of good function in those domains. Overall, this work may provide significant benefit to individuals suffering from dementia through potentially improved cognition and independence, while also providing long-term benefits for future research aiming to improve cognition in dementia.
- Conditions
- Dementia, Alzheimer s Disease
- Being tested
- EEG-triggered TMS
- Keywords
- Dementia, Alzheimer's Disease, transcranial magnetic stimulation, eeg, electroencephalography
- Medical subject headings
- Dementia, Alzheimer Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
EEG-triggered TMSDevice
This intervention involves delivering transcranial magnetic stimulation (TMS) to the dorsolateral prefrontal cortex (dlPFC) during working memory maintence timed to a specific electroencephalography (EEG) phase from the temporal cortex. The intervention is attempting to facilitate improved communication between the dlPFC and temporal cortex to improve working memory in people living with dementia.
| Study group | Role | What they receive |
|---|---|---|
| Intervention: EEG-triggered TMS | Experimental | The electroencephalography (EEG) triggered transcranial magnetic stimulation (TMS) arm involves receiving TMS timed to particular phases of EEG involved in working memory. TMS involves the delivery of brief current to the part of the brain that is involved in working memory. EEG involves placing 32 electrodes on the surface of then head and reading the brain's waves in real-time. TMS will be delivered to the part of the brain involved in working memory timed to EEG recorded brain waves Receives: Device: EEG-triggered TMS |
What is being measured
The primary outcome is the main question the study is designed to answer.
Forward digit span
A set of numbers will be presented one after another and you will be asked to recall them in the same order after a brief maintence period. Accuracy and reaction time will be measured
Measured: Immediately before, immediately after the 2 week intervention, 1 month and 4 months after the intervention period.
Reverse digit span
A set of digits will be presented and you must recall the digits in reverse order. Accuracy and reaction time will be measured
Measured: Immediately before, immediately after the 2 week intervention, 1 month and 4 months after the intervention period.
Sentence span
You will be presented with a set of sentences one after another. You are tasked with remembering the last word of each sentence. Then after a brief maintence period, you will be asked to repeat the last word of each sentence in the order the sentences were presented in. Accuracy and reaction time will be measured
Measured: Immediately before, immediately after the 2 week intervention, 1 month and 4 months after the intervention period.
Grocery list task
You will be presented with a set of grocery items one after another. After a brief maintence period, you will be asked to repeat the items in the same order they were presented in. Accuracy and reaction time will be measured
Measured: Immediately before, immediately after the 2 week intervention, 1 month and 4 months after the intervention period.
Montreal Cognitive Assessment (MoCA) score
The MOCA is a tool used to assess cognitive impairment. It assesses various aspects of cognition including executive function, memory, language, attention, and orientation. A score less than 25 out of 30 is considered significant for MCI.
Measured: Immediately before, immediately after the 2 week intervention, 1 month and 4 months after the intervention period.
Mini-Mental State Examination (MMSE) scores
The MMSE is a 30 point cognitive assessment that involves a variety of cognitive tasks to assess an individual's cognitive abilities. It takes 5-10 minutes to complete.
Measured: Immediately before, immediately after the 2 week intervention, 1 month and 4 months after the intervention period.
Secondary outcomes (2)
Frontotemporal EEG connectivity (imaginary component of coherence)
The investigators will measure changes in the level of connectivity between the frontal and temporal cortex during working memory through electroencephalography (EEG). This metric indicates the level of communication between brain areas.
Measured: Recorded before, immediately after the 2 week intervention, 1 month and 4 months after the intervention period.
Prefrontal theta-gamma coupling (modulation index)
Theta-gamma coupling in the prefrontal cortex (involved in coordinating the order of items stored in working memory) during working memory will be extracted from electroencephalography (EEG) recorded during working memory maintenance.
Measured: Before the intervention, immediately after the 2 week intervention, 1 month and 4 months after the intervention period.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Jun 2026
- Study start7 Jul 2026 (estimated)
- Primary completion1 Apr 2028 (estimated)
- Study completion1 Aug 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for DementiaStudies of the same condition, open and under way.
- More trials run by McMaster UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- Proof-of-concept open-label study where all participants will receive intervention
- Masking
- None (open label)
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- McMaster University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Aimee Nelson, McMaster University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07673770
- Sponsor's protocol ID
- 19029
- Acronym
- BWIBS-WM
- Status last verified
- Jul 2026
- First submitted
- 10 Apr 2026
- Last updated
- 7 Jul 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Albert, M. S. (2011). Changes in Cognition. Neurobiology of Aging, 32(0 1), S58-S63. https://doi.org/10.1016/j.neurobiolaging.2011.09.010 Alzheimer Society of Canada. (2022, September 6). Navigating the Path Forward for Dementia in Canada: The Landmark Study Report #1. Alzheimer Society of Canada. https://alzheimer.ca/en/research/reports-dementia/navigating-path-forward-landmark-report-1 Barbey, A. K., Koenigs, M., & Grafman, J. (2013). Dorsolateral Prefrontal Contributions to Human Working Memory. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior, 49(5), 1195-1205. https://doi.org/10.1016/j.cortex.2012.05.022 Bastos, A. M., & Schoffelen, J.-M. (2016). A Tutorial Review of Functional Connectivity Analysis Methods and Their Interpretational Pitfalls. Frontiers in Systems Neuroscience, 9. https://doi.org/10.3389/fnsys.2015.00175 Casarotto, S., Fecchio, M., Rosanova, M., Varone, G., D'Ambrosio, S., Sarasso, S., Pigorini, A., Russo, S., Comanducci, A., Ilmoniemi, R. J., & Massimini, M. (2022). The rt-TEP tool: Real-time visualization of TMS-Evoked Potentials to maximize cortical activation and minimize artifacts. Journal of Neuroscience Methods, 370, 109486. https://doi.org/10.1016/j.jneumeth.2022.109486 Daume, J., Gruber, T., Engel, A. K., & Friese, U. (2017). Phase-Amplitude Coupling and Long-Range Phase Synchronization Reveal Frontotemporal Interactions during Visual Working Memory. The Journal of Neuroscience, 37(2), 313. https://doi.org/10.1523/JNEUROSCI.2130-16.2016 Eldridge, S. M., Lancaster, G. A., Campbell, M. J., Thabane, L., Hopewell, S., Coleman, C. L., & Bond, C. M. (2016). Defining Feasibility and Pilot Studies in Preparation for Randomised Controlled Trials: Development of a Conceptual Framework. PloS One, 11(3), e0150205. https://doi.org/10.1371/journal.pone.0150205 Fox, M. D., Buckner, R. L., White, M. P., Greicius, M. D., & Pascual-Leone, A. (2012). Efficacy of TMS targets for depression is related to intrinsic functional connec
Study at a glance
From the registry record, last updated by the sponsor on 7 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Brain Wave Informed Non-invasive Brain Stimulation: Improving Neural Networks of Working Memory in Dementia: a Proof-of-concept Study
- ClinicalTrials.gov ID
- NCT07673770
- Acronym / sponsor ID
- BWIBS-WM / 19029
- Conditions
- Dementia, Alzheimer s Disease
- Keywords
- Dementia, Alzheimer's Disease, transcranial magnetic stimulation, eeg, electroencephalography
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- McMaster UniversityUniversity, hospital or other
- Study start
- 7 Jul 2026 (estimated)
- Primary completion
- 1 Apr 2028 (estimated)
- Study completion
- 1 Aug 2028 (estimated)
- First posted
- 29 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Working memory helps us hold information for a short time so one can think and make decisions. It keeps thoughts on track. As one gets older, working memory gets weaker. In people with dementia, it gets much worse, making it harder to talk with others, follow directions, or remember things like shopping lists.
This may happen because brain waves that support working memory fall out of sync. Researchers can see these brain waves using a test called EEG. In this study, the investigators will try to get these brain waves back in sync using a safe, non-invasive form of brain stimulation called transcranial magnetic stimulation (TMS), and will time it to each person's brain waves to make it more effective. The goal is to improve working memory in people with dementia. If successful, dementia patients may be able to be more independent taking pressure off their families.
Detailed description
Dementia is cognitive decline severe enough to interfere with daily function and is more severe than cognitive decline normally occurring as a result of aging. Two major cognitive domains which are typically impaired in dementia include executive function and learning/memory. Impairments in executive function interfere with an individual's ability to plan, organize, and switch between tasks, with impairments in this domain significantly reducing an individual's ability to perform activities of daily living (ADL). In the learning/memory domain, episodic memory and working memory are altered. Impairments in episodic memory lead to individuals being unable to recall past events or experiences, as well as being unable to learn and retain details about new experiences. Impairments in working memory lead to individuals being unable to retain information for short periods of time during the execution of a task, such as remembering what was said earlier in a conversation or remembering a set of instructions while executing them. Similar to executive function, decline in episodic and/or working memory is related to reduced ADL. Lower ADL in patients with dementia is associated with higher burden on their caregivers. Dementia caregivers in Canada provide over 580 million hours of care annually. Dementia produces a ripple effect for all Canadians through hospital stays and emergency department visits, loss of productivity from absenteeism, presenteeism, and early retirement of caregivers leading to an overall annual economic burden of over $10 billion CAD. At present, there is no gold standard treatment for reducing cognitive impairment in dementia.
While dementia is thought to be a result of a combination of structural and chemical changes in the brain, recent work has highlighted the interaction between these changes and how the brain functionally adapts to them. The 2024 Lancet Neurology Commission on dementia highlights some individuals may have the chemical and structural brain changes associated with dementia, but do not suffer cognitive decline beyond what is associated with normal aging. More specifically, a community-based autopsy study of 4,354 individuals over the age of 80 in the United Kingdom measured the number of neuropathologies including severe neuritic plaques, neurofibrillary tangles, micro \& macroinfarcts, and Lewy bodies, found that 51% of individuals with two or more significant neuropathologies did not have a clinical diagnosis of dementia. The brain's ability to withstand neuropathology without leading to cognitive decline is defined as cognitive reserve. Cognitive reserve is thought to allow recruitment of brain networks typically used for other functions or more efficient use of existing brain networks. On a neurophysiological level, it is thought that individuals with higher cognitive reserve generally have higher resting state functional connectivity between regions involved in cognition. Thus, increasing functional connectivity between brain regions involved in cognitive domains impaired in dementia may be able to improve cognitive reserve, reducing cognitive impairment in dementia.
Electroencephalography (EEG) is an effective method for measuring functional connectivity between brain regions non-invasively. EEG functional connectivity associated with proper functioning of cognitive domains impaired in dementia may provide a target biomarker to improve cognitive reserve. While EEG functional connectivity during executive function and episodic memory have been measured, there is a large degree of overlap in functional connectivity changes between executive function and working memory, likely due to both sharing some cognitive processes. Further, there are multiple studies demonstrating the causal role of EEG functional connectivity measures in working memory. Thus, EEG functional connectivity associated with working memory may provide a more promising biomarker to target for cognitive reserve.
EEG functional connectivity is a measure of the synchrony between EEG waves from two different brain regions. During successful working memory maintenance, the level of synchrony in the theta band between the frontal and temporal cortex has been shown to increase in healthy adults. Frontotemporal theta band synchrony is most commonly measured through phase-locking value (PLV). High PLV is thought to indicate stronger communication between cortices. Further, temporarily enhancing frontotemporal theta PLV using non-invasive brain stimulation known as transcranial alternating current stimulation (tACS) has been shown to restore working memory performance in older adults to the level of healthy young adults. Additionally, a metanalysis of 28 placebo-controlled studies determining the effects of different tACS protocols on working memory, found that only two forms of tACS improved working memory performance: frontotemporal theta and occipitoparietal gamma. Occipitoparietal gamma was thought to improve working memory performance as a result of many of the included studies using visual based working memory tasks. Nonetheless, these findings provide strong evidence for the role of frontotemporal theta PLV in working memory and highlight the potential for improving cognition by improving frontotemporal theta PLV long-term. At present, tACS is the only approach that can effectively improve PLV between two brain regions. However, its effects are typically temporary, lasting between 30min-70min after stimulation. Thus, enhancing PLV between two brain regions long-term may potentially produce lasting improvements in cognition in dementia.
High PLV is thought to occur due to strong synapses between two populations of neurons being recorded via EEG. If the strength of the synapses between these two populations were increased, then, theoretically their PLV would likely also increase. In the context of working memory, strengthening the synapses between neurons in the frontal and temporal cortex that generally contribute to the EEG theta band may result in a significant increase in frontotemporal theta PLV on EEG. These synapses can potentially be strengthened through a form of neuroplasticity known as long-term potentiation (LTP). LTP can potentially be induced through spike-timing dependent plasticity. Spike-timing dependent plasticity occurs through co-incident firing of the sending and receiving neurons. Considering that the frontal cortex is largely considered to be the hub for most cognitive functions, it is suggested that the frontal cortex projects onto the temporal cortex. Therefore, stimulating the frontal cortex when neurons in the temporal cortex contributing to the theta band are most likely to fire action potentials, through spike-timing dependent plasticity, may result in theta band specific LTP between the frontal and temporal cortex, in turn producing long-term enhancements in frontotemporal theta PLV.
The probability that a population of neurons will fire an action potential has previously been shown to be related to the phase of the EEG band. More specifically, non-invasive brain stimulation known as transcranial magnetic stimulation (TMS), synchronized to mu (8-13Hz) troughs results in significantly greater muscle activity than peaks or random phases. This is thought to be a result of the cortex being more excitable at troughs than any other phase. Therefore, triggering TMS over the frontal cortex at temporal cortex theta troughs, while accounting for conduction delay between the two cortices, may induce EEG theta band specific LTP between the two cortices. This approach has not been used in healthy adults or in clinical populations including Alzheimer's disease and related dementias.
The goal of this study open-label proof-of-concept study is to determine the feasibility and potential efficacy of the approach of temporal cortex theta trough triggered frontal TMS. This study will inform the design of a powered study to observe effects of EEG-TMS on working memory and will inform future work to identify and target biomarkers of other impacted cognitive domains in dementia. This study also aims to determine the potential of this technique to produce long-term improvements in working memory \& cognition in individuals suffering from dementia as well as improvements in frontotemporal theta PLV.
By improving working memory in dementia, overall cognition may be improved, dementia patients' ADL may increase, and strain on their caregivers may be reduced. This study paves the way for future work that aims to improve the cognitive domains impaired in dementia by targeting the neurophysiological biomarkers of good function in those domains. Overall, this work may provide significant benefit to individuals suffering from dementia through potentially improved cognition and independence, while also providing long-term benefits for future research aiming to improve cognition in dementia.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- Proof-of-concept open-label study where all participants will receive intervention
| Arm | Type | Receives |
|---|---|---|
| Intervention: EEG-triggered TMS | Experimental | Device: EEG-triggered TMSThe electroencephalography (EEG) triggered transcranial magnetic stimulation (TMS) arm involves receiving TMS timed to particular phases of EEG involved in working memory. TMS involves the delivery of brief current to the part of the brain that is involved in working memory. EEG involves placing 32 electrodes on the surface of then head and reading the brain's waves in real-time. TMS will be delivered to the part of the brain involved in working memory timed to EEG recorded brain waves |
Who may qualify
- Ages
- 55 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Individuals must be diagnosed with Alzheimer's Disease or related dementias by a clinician.
- Individuals must exhibit adequate oral communication skills and cognitive function sufficient to obtain a score above 10 on the MMSE
- Instructions will be delivered in English; therefore participants must demonstrate an understanding of instruction provided in English.
- Individuals must be at least 55 years or older
Key exclusion criteria (2 listed)
- Contraindications to TMS; presence of a pacemaker, metal/electrical/magnetic implants not including titanium, known history of untreated or uncontrolled psychological disorders, pregnancy, history of seizure or diagnoses of epilepsy, are taking any prescription medications that increase the risk of seizure.
- Allergy to rubbing alcohol, which is needed to prepare electromyography for TMS
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| EEG-triggered TMSThis intervention involves delivering transcranial magnetic stimulation (TMS) to the dorsolateral prefrontal cortex (dlPFC) during working memory maintence timed to a specific electroencephalography (EEG) phase from the temporal cortex. The intervention is attempting to facilitate improved communication between the dlPFC and temporal cortex to improve working memory in people living with dementia. | Device | Intervention: EEG-triggered TMS |
Primary outcome
Forward digit span
Time frame: Immediately before, immediately after the 2 week intervention, 1 month and 4 months after the intervention period.
A set of numbers will be presented one after another and you will be asked to recall them in the same order after a brief maintence period. Accuracy and reaction time will be measured
Reverse digit span
Time frame: Immediately before, immediately after the 2 week intervention, 1 month and 4 months after the intervention period.
A set of digits will be presented and you must recall the digits in reverse order. Accuracy and reaction time will be measured
Sentence span
Time frame: Immediately before, immediately after the 2 week intervention, 1 month and 4 months after the intervention period.
You will be presented with a set of sentences one after another. You are tasked with remembering the last word of each sentence. Then after a brief maintence period, you will be asked to repeat the last word of each sentence in the order the sentences were presented in. Accuracy and reaction time will be measured
Grocery list task
Time frame: Immediately before, immediately after the 2 week intervention, 1 month and 4 months after the intervention period.
You will be presented with a set of grocery items one after another. After a brief maintence period, you will be asked to repeat the items in the same order they were presented in. Accuracy and reaction time will be measured
Montreal Cognitive Assessment (MoCA) score
Time frame: Immediately before, immediately after the 2 week intervention, 1 month and 4 months after the intervention period.
The MOCA is a tool used to assess cognitive impairment. It assesses various aspects of cognition including executive function, memory, language, attention, and orientation. A score less than 25 out of 30 is considered significant for MCI.
Mini-Mental State Examination (MMSE) scores
Time frame: Immediately before, immediately after the 2 week intervention, 1 month and 4 months after the intervention period.
The MMSE is a 30 point cognitive assessment that involves a variety of cognitive tasks to assess an individual's cognitive abilities. It takes 5-10 minutes to complete.
2 secondary outcomes
Frontotemporal EEG connectivity (imaginary component of coherence)
Time frame: Recorded before, immediately after the 2 week intervention, 1 month and 4 months after the intervention period.
Prefrontal theta-gamma coupling (modulation index)
Time frame: Before the intervention, immediately after the 2 week intervention, 1 month and 4 months after the intervention period.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Jul 2026.
- BackgroundAlbert, M. S. (2011). Changes in Cognition. Neurobiology of Aging, 32(0 1), S58-S63. https://doi.org/10.1016/j.neurobiolaging.2011.09.010 Alzheimer Society of Canada. (2022, September 6). Navigating the Path Forward for Dementia in Canada: The Landmark Study Report #1. Alzheimer Society of Canada. https://alzheimer.ca/en/research/reports-dementia/navigating-path-forward-landmark-report-1 Barbey, A. K., Koenigs, M., & Grafman, J. (2013). Dorsolateral Prefrontal Contributions to Human Working Memory. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior, 49(5), 1195-1205. https://doi.org/10.1016/j.cortex.2012.05.022 Bastos, A. M., & Schoffelen, J.-M. (2016). A Tutorial Review of Functional Connectivity Analysis Methods and Their Interpretational Pitfalls. Frontiers in Systems Neuroscience, 9. https://doi.org/10.3389/fnsys.2015.00175 Casarotto, S., Fecchio, M., Rosanova, M., Varone, G., D'Ambrosio, S., Sarasso, S., Pigorini, A., Russo, S., Comanducci, A., Ilmoniemi, R. J., & Massimini, M. (2022). The rt-TEP tool: Real-time visualization of TMS-Evoked Potentials to maximize cortical activation and minimize artifacts. Journal of Neuroscience Methods, 370, 109486. https://doi.org/10.1016/j.jneumeth.2022.109486 Daume, J., Gruber, T., Engel, A. K., & Friese, U. (2017). Phase-Amplitude Coupling and Long-Range Phase Synchronization Reveal Frontotemporal Interactions during Visual Working Memory. The Journal of Neuroscience, 37(2), 313. https://doi.org/10.1523/JNEUROSCI.2130-16.2016 Eldridge, S. M., Lancaster, G. A., Campbell, M. J., Thabane, L., Hopewell, S., Coleman, C. L., & Bond, C. M. (2016). Defining Feasibility and Pilot Studies in Preparation for Randomised Controlled Trials: Development of a Conceptual Framework. PloS One, 11(3), e0150205. https://doi.org/10.1371/journal.pone.0150205 Fox, M. D., Buckner, R. L., White, M. P., Greicius, M. D., & Pascual-Leone, A. (2012). Efficacy of TMS targets for depression is related to intrinsic functional connec
- Individual participant dataSharing planned: No
Related trials for Dementia
RecruitingObservational study
PET Imaging in the Baltimore Longitudinal Study of Aging (BLSA)
Aging
Active, not recruiting
The PorchLight Project
Memory Loss, Alzheimer Disease
RecruitingPhase 2
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
Alzheimer's Disease
Active, not recruitingPhase 2
Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's Disease
Alzheimer Disease, Early Onset
Active, not recruiting
NYUCI-ES: Psychosocial Intervention to Improve Health Outcomes for Chinese and Korean ADRD Caregivers
Dementia Caregivers, Diabetes
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Ameer Hamoodi contact
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing EEG-triggered TMS in people with Dementia and Alzheimer s Disease, run by McMaster University at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 7 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Aimee Nelson ((905) 525-9140 ext. 28053, nelsonaj@mcmaster.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Forward digit span (time frame: Immediately before, immediately after the 2 week intervention, 1 month and 4 months after the intervention period.). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07673770, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jul 2026.